Low retinal toxicity of intravitreal carboplatin associated with good retinal tumour control in transgenic murine retinoblastoma.

Stéphanie LemaîtreFlorent PoyerPaul FréneauxSophie LeboucherFrançois DozNathalie CassouxCarole D Thomas

Published in: Clinical & experimental ophthalmology (2020)

This preclinical study suggests that intravitreal injection of carboplatin has a low toxicity and could be evaluated in clinical practice to treat patients suffering from retinoblastoma.

Keyphrases

diabetic retinopathy
optical coherence tomography
clinical practice
vascular endothelial growth factor
end stage renal disease
newly diagnosed
ejection fraction
phase ii study
squamous cell carcinoma
optic nerve
ultrasound guided
patient reported outcomes
bone marrow